The earnings call highlighted strategic advancements, new partnerships, and operational improvements, but was weighed down by decreased quarterly revenue and a significant net loss. The company remains optimistic about future growth and financial recovery.

Company Guidance -

Q4 2025

During Lifecore Biomedical's fiscal 2025 third quarter earnings call, the company reported revenues of $35.2 million, marking a 2% decrease from the prior year's $35.7 million. This decline was primarily attributed to a $1.5 million reduction in CDMO revenues, offset by a $1 million increase in hyaluronic acid manufacturing revenues. Gross profit for the quarter was $9.8 million, compared to $11.9 million in the previous year, with the net loss recorded at $14.8 million, contrasting sharply with a net income of $15.6 million from the same period last year. Selling, general, and administrative expenses totaled $10.1 million, slightly up from $9.8 million, driven by increased litigation expenses. Adjusted EBITDA was reported at $5.7 million, down from $6.4 million in the prior year. The company's guidance for fiscal 2025 remains unchanged, with expected revenues between $126.5 million and $130 million, and adjusted EBITDA forecasted between $19 million and $21 million.

New Customer Agreements and Partnerships

Lifecore signed multiple new agreements with both new and existing customers, including a significant agreement with Nirsum Laboratories and a post-quarter agreement with Humanetics.

Improved Financial Management

Cash flow from operations turned positive at $2 million, despite legacy legal expenses, and the company is on track to be cash flow positive in the second half of the fiscal year.

Strategic Focus and Future Growth Plans

Lifecore is focused on a 12% revenue CAGR and increasing EBITDA margins to over 25% over the next few years, with significant advancements in their late-stage pipeline towards commercialization.

Operational Efficiencies and Cost Reductions

Lifecore made substantial improvements in reducing operational expenses, improving productivity, and enhancing fermentation processing efficiency.

Lifecore Biomedical (LFCR) Earnings, Revenues Date & History

The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced

Daily Earnings Calendar >

LFCR Earnings History

Report Date	Fiscal Quarter	Forecast / EPS	Last Year's EPS	EPS YoY Change	Slides	Play Transcript
Aug 07, 2025	2025 (Q4)	-0.10 / -	-0.16	―	―	―
Apr 03, 2025	2025 (Q3)	-0.15 / -0.47	0.4	-217.50% (-0.87)
Jan 02, 2025	2025 (Q2)	-0.29 / -0.25	0.39	-164.10% (-0.64)	―
Oct 04, 2024	2025 (Q1)	-0.49 / -0.53	-0.35	-51.43% (-0.18)	―
Aug 26, 2024	2024 (Q4)	-0.12 / -0.16	-1.19	86.55% (+1.03)	―
Apr 02, 2024	2024 (Q3)	-0.06 / -0.06	-1.33	95.49% (+1.27)	―	―
Jan 03, 2024	2024 (Q2)	-0.13 / -0.13	-0.42	69.05% (+0.29)	―	―
Oct 03, 2023	2024 (Q1)	- / -	―	―	―	―
Aug 31, 2023	2023 (Q4)	-0.39 / -0.35	-0.41	14.63% (+0.06)	―
Jun 01, 2023	2023 (Q3)	-0.45 / -1.19	-1.24	4.03% (+0.05)	―

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat

Missed

LFCR Earnings-Related Price Changes

Report Date	Price 1 Day Before	Price 1 Day After	Percentage Change
Apr 03, 2025	$6.81	$5.29	-22.32%
Jan 02, 2025	$6.66	$7.62	+14.41%
Oct 04, 2024	$4.70	$5.38	+14.47%
Aug 26, 2024	$6.34	$4.74	-25.24%

Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.

FAQ

When does Lifecore Biomedical, Inc. (LFCR) report earnings?

Lifecore Biomedical, Inc. (LFCR) is schdueled to report earning on Aug 07, 2025, After Close (Confirmed).

What is Lifecore Biomedical, Inc. (LFCR) earnings time?

Lifecore Biomedical, Inc. (LFCR) earnings time is at Aug 07, 2025, After Close (Confirmed).

Where can I see when companies are reporting earnings?

You can see which companies are reporting today on our designated earnings calendar.

What companies are reporting earnings today?

You can see a list of the companies which are reporting today on TipRanks earnings calendar.

What is LFCR EPS forecast?

LFCR EPS forecast for the fiscal quarter 2025 (Q4) is -0.1.

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing